Analysis of the treatment of AECOPD patient complicated with high-risk case of Pseudomonas aeruginosa and immunocompromised condition
-
摘要: 目的 探讨慢性阻塞性肺病急性加重(AECOPD)患者出现铜绿假单胞菌感染的危险因素及免疫调节对治疗该病的意义。 方法 临床药师参与1例免疫力低下且反复发作的AECOPD患者方案的制订与用药监护,对患者的抗菌药物选用及免疫力调节提供了建议并给予理论支持。 结果 临床药师给出合理化用药建议,使抗感染方案更加合理有效。 结论 临床药师协助医师制订用药方案,可以为患者提供更优化的个体化治疗。
-
关键词:
- 铜绿假单胞菌 /
- 免疫力低下 /
- 慢性阻塞性肺病急性加重
Abstract: Objective To investigate risk factors for Pseudomonas aeruginosa infected AECOPD patients and the significance of immune regulation. Methods The clinical pharmacist is involved in the administration and guardianship of immunocompromised patients with recurrent AECOPD. The clinical pharmacist provides recommendations and theoretical support in antimicrobial drug selection and regulating immunity. Results Clinical pharmacist gave rationalized medication recommendations. It made anti-infective programs more reasonable and effective. Conclusion By assisting physicians in formulating regimens, clinical pharmacists can provide more optimal individualized treatment for patients.-
Key words:
- Pseudomonas aeruginosa /
- immunocompromised /
- AECOPD
-
[1] 慢性阻塞性肺疾病急性加重(AECOPD)诊治专家组.慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识(2014年修订版)[J].国际呼吸杂志,2014,34(1):1-11. [2] 中华医学会呼吸病学会分会感染学组.铜绿假单胞菌下呼吸道感染诊治专家共识[J].中华结核和呼吸杂志,2014,37(1):9-15. [3] 曹雪涛.医学免疫学[M].北京:人民卫生出版社,2009:105-107,149. [4] 李 琛,张玲玲,赵洪茹.老年慢性阻塞性肺疾病急性加重期患者细胞免疫功能的变化[J].中国临床研究,2010,23(12):1094-1095. [5] 邹 静,刘 斌,陈雪华,等.肺癌患者外周血T 淋巴细胞亚群变化特点及临床意义[J].中国免疫学杂志,2010,26(11):1016-1020. [6] Lacedonia D,Salerno FC,Sabato R,et al. Airway cell patterns in patients suffering from COPD and OSAS (overlap syndrome)[J].Respair Med,2011,105(2):303.
计量
- 文章访问数: 2888
- HTML全文浏览量: 254
- PDF下载量: 547
- 被引次数: 0